13-ETHOXY-LABDA-8(17),11,14-TRIEN-19-OIC-ACID-METHYLFTALIMIDE-ESTER
Compound with spectra: 1 NMR
| SpectraBase Compound ID | DuOMemISjcI |
|---|---|
| InChI | InChI=1S/2C31H39NO5/c2*1-7-29(4,37-8-2)19-16-24-21(3)14-15-25-30(24,5)17-11-18-31(25,6)28(35)36-20-32-26(33)22-12-9-10-13-23(22)27(32)34/h2*7,9-10,12-13,16,19,24-25H,1,3,8,11,14-15,17-18,20H2,2,4-6H3/b2*19-16+/t24-,25+,29+,30+,31-;24-,25+,29-,30+,31-/m00/s1 |
| InChIKey | YVWZVMCODOQDSK-LFNXMOCISA-N |
| Mol Weight | 1011.3 g/mol |
| Molecular Formula | C62H78N2O10 |
| Exact Mass | 1010.565647 g/mol |
| Enantiomer InChIKey | YVWZVMCODOQDSK-BLYRKDACSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
12-HYDROXY-LABDA-8(17),13(16),14-TRIEN-19-OIC-ACID-METHYLFTALIMIDE-ESTER
#1D;(1S,4A-R,5S,8A-R)-5-[2'-(5'',8''-DIACETOXY-1'',4''-DIHYDRONAPHTHALEN-2''-YL)-ETHYL]-1,4A-DIMETHYL-6-METHYLENE-DECAHYDRONAPHTHALENE-1-CARBOXYLIC-ACID-METHYLESTER
sandaracopimaric acid pentafluorobenzyl ester
PLATYCLOLACTONIC-ACID-METHYLESTER
GOMOJOSIDE-A;LABDA-8(17),13E-DIEN-15-O-BETA-GLUCOPYRANOSYL-19-OIC-ACID-19-O-BETA-GLUCOPYRANOSYLESTER
16-oxo-13,16-oxakaurenic acid trimethylsilylmethyl ester dev.
BETA-D-GLUCOPYRANOSYL-8-(17),13-ENT-LABDADIEN-16,15-OLID-18-OATE
METHYL-(13S)-ENT-16-HYDROXY-8-ALPHA,13-EPOXY-LABD-14-EN-18-OATE
(1-S,4A-R,5-S,8A-R)-5-[2'-(5'',8''-DIACETOXY-NAPHTHALEN-2''-YL)-ETHYL]-1,4A-DIMETHYL-6-METHYLENE-DECAHYDRONAPHTHALENE-1-CARBOXYLIC-ACID-METHYLESTER
neoabietic acid pentafluorobenzyl ester
| Title | Journal or Book | Year |
|---|---|---|
| Anti-tumor Promoting Diterpenes from the Stem Bark of Thuja standishii (Cupressaceae) | Bioorganic & Medicinal Chemistry | 2001 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.